The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.

@article{Doolan2007TheUC,
  title={The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.},
  author={Denise L. Doolan and Daniel A Freilich and Gary T. Brice and Timothy H. Burgess and Mara P Berzins and Robert L. Bull and Norma L. Graber and Jason Dabbs and L Shatney and David L. Blazes and Lolita Bebris and Maria Malone and John F. Eisold and Alfred J. Mateczun and Gregory J. Martin},
  journal={The Journal of infectious diseases},
  year={2007},
  volume={195 2},
  pages={
          174-84
        }
}
BACKGROUND Bioterrorism-related anthrax exposures occurred at the US Capitol in 2001. Exposed individuals received antibiotics and anthrax vaccine adsorbed immunization. METHODS A prospective longitudinal study of 124 subjects--stratified on the basis of spore exposure, nasopharyngeal culture results, and immunization status from inside and outside an epidemiologically defined exposure zone--was performed to describe clinical outcome and immune responses after Bacillus anthracis exposure… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Learning from the 2001 anthrax attacks: immunological characteristics.

  • The Journal of infectious diseases
  • 2007
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Anthrax threat: a review of clinical and diagnostic measures.

  • Journal of the Egyptian Society of Parasitology
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 46 REFERENCES

targeting human papillomavirus types 6 , 11 , 16 , and 18

LA Barakat, HL Quentzel, JA Jernigan
  • 2006

: immunogenicity and safety of a dose - reduction , route - change comparison study in humans

PR Pittman, D Hack, J Mangiafico
  • vaccine
  • 2002

Anthrax sent through mail gained potency by the letter. The New York Times 7 May 2002:A1

WJ Broad, D. Johnston
  • 2002